Richard Bayliss combines topics linked to NODAL with his work on Internal medicine. He merges many fields, such as Nuclear medicine and Cancer, in his writings. Richard Bayliss connects Cancer with Nuclear medicine in his study. His Radiology study frequently draws connections to adjacent fields such as Radiation therapy. His study ties his expertise on Radiology together with the subject of Radiation therapy. Clinical significance is closely attributed to Internal medicine in his study. His study in Malignant pleural effusion extends to Crizotinib with its themes. His Oncology research extends to Malignant pleural effusion, which is thematically connected. Oncology is closely attributed to Alectinib in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structural basis of Aurora-A activation by TPX2 at the mitotic spindle.
Richard Bayliss;Teresa Sardon;Isabelle Vernos;Elena Conti.
Molecular Cell (2003)
Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking.
Richard Bayliss;Trevor Littlewood;Murray Stewart.
web science (2000)
Cell cycle regulation by the NEK family of protein kinases
Andrew M. Fry;Laura O'Regan;Sarah R. Sabir;Richard Bayliss.
Journal of Cell Science (2012)
Glfg and Fxfg Nucleoporins Bind to Overlapping Sites on Importin-Beta
Richard Bayliss;Trevor Littlewood;Lisa A. Strawn;Susan R. Wente.
Journal of Biological Chemistry (2002)
Interaction between NTF2 and xFxFG-containing nucleoporins is required to mediate nuclear import of RanGDP.
Richard Bayliss;Katharina Ribbeck;Debra Akin;Helen M Kent.
Journal of Molecular Biology (1999)
Structural basis for the interaction between NTF2 and nucleoporin FxFG repeats.
Richard Bayliss;Sara W. Leung;Rosanna P. Baker;B.Booth Quimby;B.Booth Quimby.
The EMBO Journal (2002)
Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog.
Daniel T Rogerson;Amit Sachdeva;Kaihang Wang;Tamanna Haq.
Nature Chemical Biology (2015)
Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer.
C.G. Woo;S. Seo;S.W. Kim;S.J. Jang.
Annals of Oncology (2017)
Molecular mechanism of translocation through nuclear pore complexes during nuclear protein import
Murray Stewart;Rosanna P Baker;Richard Bayliss;Lesley Clayton.
FEBS Letters (2001)
Crystal structures of the phosphorylated BRI1 kinase domain and implications for brassinosteroid signal initiation.
Daniel Bojar;Jacobo Martinez;Julia Santiago;Vladimir Rybin.
Plant Journal (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: